OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders
Tania Kümpfel, Sandra Thiel, Ingrid Meinl, et al.
Neurology Neuroimmunology & Neuroinflammation (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Tania Kümpfel, Sandra Thiel, Ingrid Meinl, et al.
Neurology Neuroimmunology & Neuroinflammation (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Showing 51-75 of 57 citing articles:
Impact of Continuous Ofatumumab Exposure During Pregnancy in Multiple Sclerosis
Simon Hefner, Tiago Lerda Casaccia, Edda Hofstaetter, et al.
Neurology Clinical Practice (2024) Vol. 15, Iss. 1
Closed Access
Simon Hefner, Tiago Lerda Casaccia, Edda Hofstaetter, et al.
Neurology Clinical Practice (2024) Vol. 15, Iss. 1
Closed Access
Case report: Satralizumab as an adjunctive therapy for AQP-4 antibody and MOG antibody dual-negative optic neuritis in a third-trimester pregnancy case
Chuan‐bin Sun, Zhe Liu
Frontiers in Medicine (2024) Vol. 11
Open Access
Chuan‐bin Sun, Zhe Liu
Frontiers in Medicine (2024) Vol. 11
Open Access
Inebilizumab for neuromyelitis optica spectrum disorders in Italy: a budget impact model
Carlo Lazzaro, Nicola Amedeo Mazzanti, Silvia Rossi, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 23, Iss. 10, pp. 1185-1200
Open Access | Times Cited: 1
Carlo Lazzaro, Nicola Amedeo Mazzanti, Silvia Rossi, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 23, Iss. 10, pp. 1185-1200
Open Access | Times Cited: 1
Anti-CD20 therapy in pregnancy: Balancing risks and benefits
Sandra Thiel, Kerstin Hellwig
Multiple Sclerosis Journal (2023) Vol. 30, Iss. 2, pp. 274-275
Closed Access | Times Cited: 1
Sandra Thiel, Kerstin Hellwig
Multiple Sclerosis Journal (2023) Vol. 30, Iss. 2, pp. 274-275
Closed Access | Times Cited: 1
Ocrelizumab - long-term efficacy and safety in real-world clinical practice in patients with relapsing-remitting multiple sclerosis
Martin Elišák
Neurologie pro praxi (2022) Vol. 23, Iss. 3, pp. 233-237
Open Access | Times Cited: 1
Martin Elišák
Neurologie pro praxi (2022) Vol. 23, Iss. 3, pp. 233-237
Open Access | Times Cited: 1
Neue Therapieansätze bei Multipler Sklerose inkl. Stellenwert älterer Präparate
Hernán Inojosa, Tjalf Ziemssen
Neurologie up2date (2023) Vol. 06, Iss. 02, pp. 141-162
Closed Access
Hernán Inojosa, Tjalf Ziemssen
Neurologie up2date (2023) Vol. 06, Iss. 02, pp. 141-162
Closed Access
